ASPIRE BIOPHARMA HLDGS INC
Q2 2026 13F Holders
Symbol
ASBP
CUSIP
738920305
Type
Equity
Class
COM
Num filings
12
Total reported value, excl. options
$251 k
Compare 2026 Q2 to
Manager
Report Date
Value ($000)
Shares
Option Type